Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $190 | $125 | $132 | $99 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $8 | $5 | $8 |
| Inventory | $6 | $6 | $8 | $8 |
| Other Curr. Assets | $9 | $4 | $5 | $4 |
| Total Curr. Assets | $208 | $144 | $150 | $119 |
| Property Plant & Equip (Net) | $43 | $43 | $42 | $43 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $1 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $44 | $44 | $43 | $44 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $252 | $187 | $193 | $163 |
| Liabilities | – | – | – | – |
| Payables | $9 | $8 | $4 | $5 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $3 | $2 | $2 |
| Other Curr. Liab. | $12 | $8 | $6 | $12 |
| Total Curr. Liab. | $21 | $19 | $12 | $18 |
| LT Debt | $0 | $0 | $0 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1 | $1 |
| Total Liabilities | $21 | $19 | $12 | $23 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$808 | -$776 | -$748 | -$731 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $1,039 | $944 | $928 | $871 |
| Total Equity | $231 | $168 | $180 | $140 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $252 | $187 | $193 | $163 |
| Net Debt | -$190 | -$125 | -$131 | -$93 |